Abstract
Objective: To evaluate the effect of nasal steroid treatment on dry eye and rhinitis in the geriatric population presenting with both rhinitis and dry eye. Material and Methods: In this single-center clinical study 31 (62 eyes) older adults (age >65 years) with rhinitis and dry eye were included. The symptoms and findings of the patients were compared with the total nasal symptom score (TNSS), the ocular surface disease index (OSDI), Schirmer I test, and the tear break-up time (TBUT) before and after nasal steroid treatment (beclomethasone dipropionate), with a dose of 2×2 puff (50 μg) for 4 weeks. Intraocular pressure (IOP) values were also measured before and after treatment. All rhinitis cases (allergic and non-allergic) in the geriatric population were included in the study. Results: TNSS, OSDI score, and Schirmer and TBUT values improved significantly after nasal steroid treatment (beclomethasone dipropionate) (p<0.001). No significant change was detected in IOP values in the right or left eyes (p=0.608 and p=0.062, respectively). Conclusion: Nasal steroid treatment at the recommended doses can be effective for both rhinitis and dry eye symptoms without affecting the IOP in older adults, thus may reduce the need for multiple medications for dry eye symptoms. Our study should be supported with further studies designed in larger series.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
